Sponsor:
Terremoto Biosciences Inc.
Code:
NCT07109726
Conditions
Breast Cancer
Endometrial Cancer
Ovarian Cancer
Lung Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TER-2013
Fulvestrant injection
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-17. This information was provided to ClinicalTrials.gov by Terremoto Biosciences Inc. on 2025-12-02.